Skip to main content
Signal8

Cardiol Therapeutics Inc. (CRDL) Form 6-K — May 26, 2026

$CRDLForm 6-KFiled May 26, 2026, 8:58 AM ET0001104659-26-066043Original filing

Cardiol Therapeutics Inc. filed a 6-K containing its management information circular for the annual meeting of shareholders, detailing board composition and voting securities. The filing confirms that MM Asset Management Inc., on behalf of MMCAP International Inc. SPC, holds approximately 13.3% of outstanding shares and warrants representing an additional 17.4% on a partially diluted basis.

Key figures

Shares Outstanding
115272240
Major Shareholder Shares
15352317
Major Shareholder Percent
13.3
Available For Future Issuance
7503768
Outstanding Options RSUs PSUs
9787068
Weighted Average Exercise Price
1.73
Major Shareholder Warrant Shares
5711539
Major Shareholder Warrant Percent
17.4

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Cardiol Therapeutics Inc. (CRDL) Form 6-K — May 26, 2026: AI Analysis | Signal8